Palvella Therapeutics (PVLA) Total Liabilities: 2013-2024
Historic Total Liabilities for Palvella Therapeutics (PVLA) over the last 11 years, with Sep 2024 value amounting to $107.9 million.
- Palvella Therapeutics' Total Liabilities rose 273.89% to $107.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $107.9 million, marking a year-over-year increase of 273.89%. This contributed to the annual value of $11.4 million for FY2023, which is 83.08% down from last year.
- As of Q3 2024, Palvella Therapeutics' Total Liabilities stood at $107.9 million, which was up 1.93% from $105.9 million recorded in Q2 2024.
- Over the past 5 years, Palvella Therapeutics' Total Liabilities peaked at $110.3 million during Q3 2021, and registered a low of $11.4 million during Q4 2023.
- Moreover, its 3-year median value for Total Liabilities was $67.6 million (2022), whereas its average is $69.0 million.
- Per our database at Business Quant, Palvella Therapeutics' Total Liabilities plummeted by 83.08% in 2023 and then skyrocketed by 273.89% in 2024.
- Over the past 5 years, Palvella Therapeutics' Total Liabilities (Quarterly) stood at $74.0 million in 2020, then soared by 38.96% to $102.8 million in 2021, then slumped by 34.28% to $67.6 million in 2022, then slumped by 83.08% to $11.4 million in 2023, then skyrocketed by 273.89% to $107.9 million in 2024.
- Its Total Liabilities stands at $107.9 million for Q3 2024, versus $105.9 million for Q2 2024 and $106.4 million for Q1 2024.